Package 72603-171-01

Brand: famotidine

Generic: famotidine
NDC Package

Package Facts

Identity

Package NDC 72603-171-01
Digits Only 7260317101
Product NDC 72603-171
Product ID 72603-171_04aaf2b3-3610-056f-e063-6394a90a91df
Description

50 mL in 1 BOTTLE (72603-171-01)

Marketing

Marketing Status
Marketed Since 2023-09-07
Brand famotidine
Generic famotidine
Sample Package No

Linked Drug Pages (1)

Famotidine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "04aaf2b3-3610-056f-e063-6394a90a91df", "openfda": {"nui": ["N0000000151", "N0000175784"], "upc": ["0372603171013"], "unii": ["5QZO15J2Z8"], "rxcui": ["310274"], "spl_set_id": ["04aaf296-f136-29d7-e063-6294a90affe1"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]"], "manufacturer_name": ["NorthStar Rx LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 mL in 1 BOTTLE (72603-171-01)", "package_ndc": "72603-171-01", "marketing_start_date": "20230907"}], "brand_name": "Famotidine", "product_id": "72603-171_04aaf2b3-3610-056f-e063-6394a90a91df", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Histamine H2 Receptor Antagonists [MoA]", "Histamine-2 Receptor Antagonist [EPC]"], "product_ndc": "72603-171", "generic_name": "Famotidine", "labeler_name": "NorthStar Rx LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Famotidine", "active_ingredients": [{"name": "FAMOTIDINE", "strength": "40 mg/5mL"}], "application_number": "ANDA215043", "marketing_category": "ANDA", "marketing_start_date": "20230907", "listing_expiration_date": "20261231"}